3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Urinary Incontinence
1
Stomach Neoplasms
1
Sexual Dysfunction, Physiological
1
Rectal Neoplasms
1
Interventions
Oxaliplatin
47
Capecitabine
46
Fluorouracil
40
Leucovorin
30
Radiotherapy
25
Irinotecan
20
Chemoradiotherapy
14
Bevacizumab
14
Cetuximab
12
Neoadjuvant Therapy
11
Folfox protocol
11
Chemotherapy, Adjuvant
11
Laparoscopy
10
XELOX
9
Drug Therapy
9
Surgical Procedures, Operative
6
Robotic Surgical Procedures
5
Radiation
5
Mastectomy, Segmental
5
Surveys and Questionnaires
4
Radiotherapy, Intensity-Modulated
4
Panitumumab
4
Gemcitabine
4
durvalumab
3
Simvastatin
3
Magnetic Resonance Spectroscopy
3
Indocyanine Green
3
FOLFOXIRI protocol
3
tislelizumab
2
regorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Rectal Neoplasms
×
Robotics
×
Clear all
NCT03209076
2019-10-16
RAR
Instituto Nacional de Cancer, Brazil
Phase NA
Unknown
120 enrolled